Efficacy and safety of S1based chemotherapy as first-line treatment in colorectal cancer: A meta-analysis of randomized controlled trials

Annals of Oncology ◽

10.1093/annonc/mdy431.010 ◽

2018 ◽

Vol 29 ◽

pp. ix31

Author(s):

Z. Wang ◽

Y.S. Zang ◽

X.L. Liu ◽

G.M. Zhang ◽

G.L. Cheng

Keyword(s):

Colorectal Cancer ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Controlled Trials ◽

Line Treatment ◽

Efficacy And Safety ◽

Randomized Controlled ◽

First Line Treatment

Download Full-text

Intratympanic vs systemic use of steroids as first-line treatment for sudden hearing loss: A meta-analysis of randomized, controlled trials

Journal of Otology ◽

10.1016/j.joto.2021.02.001 ◽

2021 ◽

Author(s):

Ting Yang ◽

Hui Liu ◽

Fangyao Chen ◽

An Li ◽

Zhou Wang ◽

...

Keyword(s):

Hearing Loss ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Sudden Hearing Loss ◽

Controlled Trials ◽

Line Treatment ◽

Randomized Controlled ◽

First Line Treatment

Download Full-text

Topotecan plus carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a meta-analysis of randomized controlled trials

Journal of Chemotherapy ◽

10.1179/1120009x12z.0000000002 ◽

2012 ◽

Vol 24 (2) ◽

pp. 67-73 ◽

Author(s):

Hui Zhang ◽

Lin Jia ◽

Yintao Xu ◽

Xun Clare Zhou ◽

Beihua Kong ◽

...

Keyword(s):

Ovarian Cancer ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Advanced Ovarian Cancer ◽

Controlled Trials ◽

Line Treatment ◽

Randomized Controlled ◽

First Line Treatment

Download Full-text

Is Antimicrobial Susceptibility Testing Necessary Before First-line Treatment for Helicobacter pylori Infection? -Meta-analysis of Randomized Controlled Trials-

Internal Medicine ◽

10.2169/internalmedicine.49.3031 ◽

2010 ◽

Vol 49 (12) ◽

pp. 1103-1109 ◽

Author(s):

Yuan Wenzhen ◽

Li Yumin ◽

Guan Quanlin ◽

Yang Kehu ◽

Jiang Lei ◽

...

Keyword(s):

Helicobacter Pylori ◽

Randomized Controlled Trials ◽

Antimicrobial Susceptibility ◽

Susceptibility Testing ◽

Meta Analysis ◽

Controlled Trials ◽

Line Treatment ◽

Randomized Controlled ◽

First Line Treatment

Download Full-text

The efficacy of bevacizumab plus paclitaxel as first-line treatment for HER2-negative metastatic breast cancer: a meta-analysis of randomized controlled trials

Tumor Biology ◽

10.1007/s13277-014-1635-4 ◽

2014 ◽

Vol 35 (5) ◽

pp. 4841-4848 ◽

Author(s):

Xuan Wang ◽

Chun Huang ◽

Man Li ◽

Yanjun Gu ◽

Yanfen Cui ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Metastatic Breast ◽

Controlled Trials ◽

Line Treatment ◽

Randomized Controlled ◽

First Line Treatment

Download Full-text

1226P Efficacy and safety of Anti-EGFR TKIs combined with bevacizumab or ramucirumab in the first-line treatment of non-small cell lung cancer: Meta-analysis of randomized controlled trials

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1831 ◽

2021 ◽

Vol 32 ◽

pp. S972-S973

Author(s):

Y. Ergün ◽

G. Uçar ◽

Y. Açıkgöz ◽

M. Dirikoç ◽

S. Aktürk Esen ◽

...

Keyword(s):

Meta Analysis ◽

Controlled Trials ◽

Line Treatment ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Randomized Controlled ◽

Egfr Tkis ◽

First Line Treatment

Download Full-text

Overall survival benefits for irinotecan-containing regimens as first-line treatment for advanced gastric cancer: An updated meta-analysis of ten randomized controlled trials

International Journal of Cancer ◽

10.1002/ijc.27775 ◽

2012 ◽

Vol 132 (2) ◽

pp. E66-E73 ◽

Author(s):

Wei-Xiang Qi ◽

Zan Shen ◽

Feng Lin ◽

Yuan-Jue Sun ◽

Da-Liu Min ◽

...

Keyword(s):

Gastric Cancer ◽

Overall Survival ◽

Randomized Controlled Trials ◽

Advanced Gastric Cancer ◽

Meta Analysis ◽

Controlled Trials ◽

Line Treatment ◽

Randomized Controlled ◽

First Line Treatment

Download Full-text

First-Line Treatment Options for Advanced Gastric/Gastroesophageal Junction (G/GEJ) Cancer Patients With PD-L1-Positive: A Meta-Analysis of Randomized Controlled Trials

SSRN Electronic Journal ◽

10.2139/ssrn.4003219 ◽

2022 ◽

Author(s):

Ling Fan ◽

Ning Lu ◽

Lingmin Zhang ◽

Manli Cui ◽

Jie Zhang ◽

...

Keyword(s):

Randomized Controlled Trials ◽

Cancer Patients ◽

Meta Analysis ◽

Treatment Options ◽

Gastroesophageal Junction ◽

Controlled Trials ◽

Line Treatment ◽

Randomized Controlled ◽

First Line Treatment

Download Full-text

S-1-based versus 5-FU-based chemotherapy as first-line treatment in advanced gastric cancer: a meta-analysis of randomized controlled trials

Tumor Biology ◽

10.1007/s13277-014-2099-2 ◽

2014 ◽

Vol 35 (8) ◽

pp. 8201-8208 ◽

Author(s):

Dan-Hong Li ◽

Zhen-Kui Pan ◽

Feng Ye ◽

Han-Xiang An ◽

Jing-Xun Wu

Keyword(s):

Gastric Cancer ◽

Randomized Controlled Trials ◽

Advanced Gastric Cancer ◽

Meta Analysis ◽

Controlled Trials ◽

Line Treatment ◽

Randomized Controlled ◽

First Line Treatment

Download Full-text

Comment on Wang et al.: The efficacy of bevacizumab plus paclitaxel as first-line treatment for HER2-negative metastatic breast cancer: a meta-analysis of randomized controlled trials

Tumor Biology ◽

10.1007/s13277-014-1924-y ◽

2014 ◽

Vol 35 (7) ◽

pp. 6183-6183 ◽

Author(s):

Jun Li ◽

Yunfeng Yao ◽

Juehua Jing

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Metastatic Breast ◽

Controlled Trials ◽

Line Treatment ◽

Randomized Controlled ◽

First Line Treatment

Download Full-text

Moxifloxacin-Based Triple Therapy Versus Clarithromycin-Based Triple Therapy for First-Line Treatment of Helicobacter pylori Infection: A Meta-Analysis of Randomized Controlled Trials

Internal Medicine ◽

10.2169/internalmedicine.48.2344 ◽

2009 ◽

Vol 48 (24) ◽

pp. 2069-2076 ◽

Author(s):

Yuan Wenzhen ◽

Yang Kehu ◽

Ma Bin ◽

Li Yumin ◽

Guan Quanlin ◽

...

Keyword(s):

Helicobacter Pylori ◽

Randomized Controlled Trials ◽

Triple Therapy ◽

Meta Analysis ◽

Helicobacter Pylori Infection ◽

Controlled Trials ◽

Line Treatment ◽

Randomized Controlled ◽

First Line Treatment

Download Full-text